Commentary

The steep costs of disrupting gut-barrier harmony


 

Practical advice for clinicians and patients

How do you advise patients to avoid gut-barrier disruption?

It is important to educate and counsel patients about the long list of risk factors, many of which are closely related to a Western diet and lifestyle, which can increase their risk for leaky gut.

Once one has it, can it be repaired? Can you share a bit about your protocols in general terms?

Many interventions have been shown to improve intestinal permeability. They include berberine, butyrate, caloric restriction and fasting, curcumin, dietary fiber (prebiotics), moderate exercise, fermented food, fish oil, glutamine, quercetin, probiotics, vagus nerve stimulation, vitamin D, and zinc.

Protocols have to be tailored to patients and their risk factors, diet, and lifestyle.

What are some tips from a nutrition and lifestyle standpoint that patients can follow to ensure a robust gut barrier?

It is important to emphasize a high-fiber diet with naturally fermented food, incorporating time-restricted eating, such as eating an early dinner and nothing else before bedtime, a moderate exercise routine, and gut-brain modulation with techniques such as acupuncture that can incorporate vagus nerve stimulation. Limited safe precision supplementation can be discussed on an individual basis based on the patient’s interest, additional testing, and other existing health conditions.

Dr. Akash Goel is a clinical assistant professor of medicine at Weill Cornell in gastroenterology and hepatology. He has disclosed no relevant financial relationships. His work has appeared on networks and publications such as CNN, The New York Times, Time Magazine, and Financial Times. He has a deep interest in nutrition, food as medicine, and the intersection between the gut microbiome and human health.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

SGLT2 inhibitors in type 2 diabetes linked to lower risk of developing GI cancers
MDedge Family Medicine
Dupilumab promising for children aged 1-11 with EoE
MDedge Family Medicine
GI symptoms during menopause deserve attention
MDedge Family Medicine
Review finds no CV or VTE risk signal with use of JAK inhibitors for skin indications
MDedge Family Medicine
FDA OKs first ustekinumab biosimilar
MDedge Family Medicine
Does diabetes affect colorectal cancer outcomes?
MDedge Family Medicine
Gut microbiome variations may be predictive of precancerous colonic lesions, CRC
MDedge Family Medicine
FDA OKs new treatment for erosive esophagitis
MDedge Family Medicine
Popular liver supplements lack data supporting efficacy, study shows
MDedge Family Medicine
Review estimates acne risk with JAK inhibitor therapy
MDedge Family Medicine